Mark T. Hegel, PhD
Professor of Psychiatry
Professor of Community and Family Medicine
Professor of The Dartmouth Institute
Community and Family Medicine
The Dartmouth Institute
Georgia State University, Atlanta, GA - PhD 1988
University of Hartford, West Hartford, CT - MA 1982
Assumption College, Worcester, MA - BS 1979
New Hampshire-Dartmouth Psychiatric Research Center
Department of Psychiatry
Dartmouth-Hitchcock Medical Center
Lebanon NH 03756
Behavioral health services in medical patients; Electronic tools for delivery of behavioral health interventions
Principal Investigator: NCI, “Participation Restrictions in Young-Middle Adult Rural Breast Cancer Survivors” (R21CA140849) (4/1/10-3/31/12), $250,000 TDC.
Principal Investigator: Johnson & Johnson, Inc., “Development and Evaluation of Enhanced HealthMedia® OVERCOMING™ Depression to Support Collaborative Depression Treatment in Primary Care: The RESPECT-D-E (Enhanced) Trial” (4/1/10-3/31/13), $689,214 TDC.
Co-Investigator: NINR “Early vs. Later Palliative Cancer Care: Clinical and Biobehavioral Effects”(R01NR011871-01). PI:Marie Bakitas, Dartmouth Medical School (10/1/09-9/30/12).
Consultant: NIMH, “Telehealth Problem Solving Therapy for Depressed Homebound Adults” (R34) PI: Namkee Choi, University of Texas at Austin (4/1/09-3/31/11).
Consultant: NIA, “Improving Care Planning and Well-being in Older Adults with Macular Degeneration” (R01AG00280422). PI: Silvia Sorensen, University of Rochester (7/09-6/14) $1,827,976 TDC
Consultant: NIMH, “Treating Subthreshold Depression in Geriatric Vision Rehabilitation”(R34MH079980). PI: Amy Horowitz, Mt Sinai School of Medicine (9/1/09-8/31/11)
Principal Investigator: Cancer and Leukemia Group B Foundation, “Feasibility of a Phone-Delivered Behavioral Activation/Problem Solving Intervention to Enhance Role Function Recovery and QOL in ‘At-Risk’ Breast Cancer Patients Following Cancer Treatment” (70804) (2008-2010), $25,000 TDC.
Co-Investigator: NEI, “Low Vision Depression Prevention Trial for Age Related Macular Degeneration” (U01 EY018819-01). PI: Barry Rovner, Thomas Jefferson University (1/1/09-12/31/13).
Principal Investigator: NCI, “Preserving Function in Rural Breast Cancer Patients Undergoing Chemotherapy” (1R03CA124200-01) (9/1/06 – 8/31/08).
Principal Investigator: NCI, “Improving Palliative Care for Patients with Cancer” (R01CA101704) (4/1/06-6/30/08).
Co-Investigator: NCI, “Cancer Patients’ Assessments Regarding Excellence (CARE)”. PI: Joan Teno, Brown University (4/1/06-6/30/07).
Co-Investigator: Robert Wood Johnson Foundation Physician Faculty Program, "Managing Depression in Mothers of Head Start Preschoolers". PI: Michael Silverstein, Boston University (1/06-12/10).
Co-Investigator: NEI, “Improving Function in Age Related Macular Degeneration”; PI: Barry Rovner, Thomas Jefferson University (10/05-9/10).
Co-Investigator: NSBRI, “Development of a Smart Medical System for Psychosocial Support During Long Duration Space Flight”; PI: James Carter, Harvard Medical School (1/05-12/07).
Family Practice Clerkship Facilitator (DMS III and IV)
Health, Society and the Physician (DMS IV)
Qualitative insights into how men with low-risk prostate cancer choosing active surveillance negotiate stress and uncertainty.
Randomized Controlled Trial of a Computerized Interactive Media-Based Problem Solving Treatment for Depression.
Uncontrolled pilot study of an Acceptance and Commitment Therapy and Health at Every Size intervention for obese, depressed women: Accept Yourself!
Autonomous, Computer-Based Behavioral Health Countermeasure Evaluation at HI-SEAS Mars Analog.
Depression in Visual Impairment Trial (DEPVIT): A Randomized Clinical Trial of Depression Treatments in People With Low Vision.
Cognitive and Affective Representations of Active Surveillance as a Treatment Option for Low-Risk Prostate Cancer.
High Prevalence of Untreated Depression in Patients Accessing Low-Vision Services.
The macular degeneration and aging study: Design and research protocol of a randomized trial for a psychosocial intervention with macular degeneration patients.
Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled Trial.
Benefits of Early Versus Delayed Palliative Care to Informal Family Caregivers of Patients With Advanced Cancer: Outcomes From the ENABLE III Randomized Controlled Trial.